Scientists have revealed that tobacco leaf and beer could hold the key to beating Ebola, which has claimed over 3,400 lives and is forecast to infect 1.4 million by January.
According to scientists, the ZMAPP medicine, made by infecting tobacco leaves with a genetically engineered virus that contains in instructions to make three antibodies to Ebola, has already been used on seven humans with the virus in the current Ebola outbreak, News.com.au reported.
Scientists have revealed that all of the 18 monkeys infected with Ebola and treated with ZMAPP in a trial survived and five of the seven humans who've used the drug lived, while one of the vaccines that could help prevent the spread of Ebola could be made in any brewery according to the head of the pharmaceutical company that makes it.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app